10 Year Anniversary of Actelion
Now full member of Interpharma, the Swiss Association of Pharmaceutical Research Companies
Jean-Paul Clozel, M.D. and Chief Executive Officer commented: "In only 10 years, Actelion has grown from a start-up with five founding team members into a profitable global biopharmaceutical company with three marketed products and a rapidly expanding pipeline, with five products expected in the final stages of clinical development by year-end. Actelion, therefore, is well prepared for the next 10 years of innovation and growth, especially thanks to our outstanding work force of close to 1600 employees."
"We are proud to welcome Actelion as a new full member," commented Thomas Cueni, Secretary General of Interpharma. "The success story of Actelion is a reflection of the dynamics and strength of Switzerland as a location for pharmaceutical research companies. Continued favourable conditions for a highly innovative and globally competitive industry are the main mission of Interpharma."
Most read news
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.